STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 98 filers reported holding STOKE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.14 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $17,298,799 | -62.9% | 4,390,558 | 0.0% | 0.36% | -58.9% |
Q2 2023 | $46,671,632 | +27.6% | 4,390,558 | 0.0% | 0.89% | +16.7% |
Q1 2023 | $36,573,348 | +2.4% | 4,390,558 | +13.4% | 0.76% | +4.5% |
Q4 2022 | $35,729,155 | -23.8% | 3,870,981 | +6.0% | 0.73% | -32.6% |
Q3 2022 | $46,889,000 | -2.8% | 3,651,823 | 0.0% | 1.08% | -13.2% |
Q2 2022 | $48,241,000 | -37.1% | 3,651,823 | +0.2% | 1.25% | -21.5% |
Q1 2022 | $76,711,000 | -12.3% | 3,644,248 | 0.0% | 1.59% | +24.4% |
Q4 2021 | $87,426,000 | -5.7% | 3,644,248 | 0.0% | 1.28% | -8.7% |
Q3 2021 | $92,710,000 | -24.4% | 3,644,248 | 0.0% | 1.40% | -24.5% |
Q2 2021 | $122,665,000 | -13.3% | 3,644,248 | 0.0% | 1.85% | -16.2% |
Q1 2021 | $141,543,000 | -35.5% | 3,644,248 | +2.8% | 2.21% | -40.0% |
Q4 2020 | $219,495,000 | +84.9% | 3,544,248 | 0.0% | 3.68% | +28.9% |
Q3 2020 | $118,697,000 | +40.5% | 3,544,248 | 0.0% | 2.86% | +20.3% |
Q2 2020 | $84,459,000 | +4.1% | 3,544,248 | 0.0% | 2.38% | -32.0% |
Q1 2020 | $81,163,000 | -19.1% | 3,544,248 | 0.0% | 3.49% | -7.7% |
Q4 2019 | $100,373,000 | +44.6% | 3,544,248 | +5.6% | 3.79% | -8.2% |
Q3 2019 | $69,401,000 | -25.0% | 3,355,466 | 0.0% | 4.13% | -16.5% |
Q2 2019 | $92,570,000 | – | 3,355,466 | – | 4.94% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ATP Life Science Ventures, L.P. | 16,786,713 | $562,187,000 | 75.80% |
RTW INVESTMENTS, LP | 3,544,248 | $118,697,000 | 2.86% |
Cormorant Asset Management, LP | 1,537,807 | $51,501,000 | 1.98% |
Redmile Group, LLC | 2,549,506 | $85,383,000 | 1.57% |
Birchview Capital, LP | 40,000 | $1,340,000 | 0.45% |
HighVista Strategies LLC | 17,082 | $572,000 | 0.42% |
Perceptive Advisors | 671,978 | $22,505,000 | 0.33% |
GILDER GAGNON HOWE & CO LLC | 1,490,153 | $49,905,000 | 0.31% |
Artal Group S.A. | 270,750 | $9,067,000 | 0.22% |
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 323 | $11,000 | 0.20% |